These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 25187037

  • 1. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.
    Johannsson G, Falorni A, Skrtic S, Lennernäs H, Quinkler M, Monson JP, Stewart PM.
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):2-11. PubMed ID: 25187037
    [Abstract] [Full Text] [Related]

  • 2. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
    Johannsson G, Skrtic S, Lennernäs H, Quinkler M, Stewart PM.
    Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
    [Abstract] [Full Text] [Related]

  • 3. Optimal glucocorticoid replacement in adrenal insufficiency.
    Øksnes M, Ross R, Løvås K.
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):3-15. PubMed ID: 25617168
    [Abstract] [Full Text] [Related]

  • 4. Novel strategies for hydrocortisone replacement.
    Debono M, Price JN, Ross RJ.
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
    [Abstract] [Full Text] [Related]

  • 5. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G, van Rossum EF, Vliegenthart J, Koper JW, van den Akker EL.
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [Abstract] [Full Text] [Related]

  • 6. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.
    Debono M, Ross RJ, Newell-Price J.
    Eur J Endocrinol; 2009 May; 160(5):719-29. PubMed ID: 19168600
    [Abstract] [Full Text] [Related]

  • 7. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
    Ekman B, Fitts D, Marelli C, Murray RD, Quinkler M, Zelissen PM.
    BMC Endocr Disord; 2014 May 09; 14():40. PubMed ID: 24884782
    [Abstract] [Full Text] [Related]

  • 8. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
    Murray RD, Ekman B, Uddin S, Marelli C, Quinkler M, Zelissen PM, the EU-AIR Investigators.
    Clin Endocrinol (Oxf); 2017 Mar 09; 86(3):340-346. PubMed ID: 27801983
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and metabolic impact of glucocorticoid replacement therapy.
    Johannsson G, Ragnarsson O.
    Front Horm Res; 2014 Mar 09; 43():33-44. PubMed ID: 24943296
    [Abstract] [Full Text] [Related]

  • 10. Health-related quality of life in primary and secondary adrenal insufficiency.
    Aulinas A, Webb SM.
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec 09; 14(6):873-88. PubMed ID: 25252879
    [Abstract] [Full Text] [Related]

  • 11. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V, Sbardella E, Gianfrilli D, Pozza C, Pasqualetti P, Morrone S, Santoni A, Naro F, Colao A, Pivonello R, Lenzi A.
    Lancet Diabetes Endocrinol; 2018 Mar 09; 6(3):173-185. PubMed ID: 29229498
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E, Joubert M, Trzepla G, Parienti JJ, Freret T, Vanthygem MC, Desailloud R, Lefebvre H, Coquerel A, Reznik Y, PHAD Study Group.
    PLoS One; 2015 Mar 09; 10(8):e0135975. PubMed ID: 26317782
    [Abstract] [Full Text] [Related]

  • 13. Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy.
    Dineen R, Stewart PM, Sherlock M.
    Clin Endocrinol (Oxf); 2019 Jan 09; 90(1):3-14. PubMed ID: 30120786
    [Abstract] [Full Text] [Related]

  • 14. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S.
    Clin Endocrinol (Oxf); 2015 Jul 09; 83(1):28-35. PubMed ID: 25400085
    [Abstract] [Full Text] [Related]

  • 15. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
    Oksnes M, Björnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, Broman JE, Triebner K, Kämpe O, Hulting AL, Bensing S, Husebye ES, Løvås K.
    J Clin Endocrinol Metab; 2014 May 09; 99(5):1665-74. PubMed ID: 24517155
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is physiological glucocorticoid replacement important in children?
    Porter J, Blair J, Ross RJ.
    Arch Dis Child; 2017 Feb 09; 102(2):199-205. PubMed ID: 27582458
    [Abstract] [Full Text] [Related]

  • 18. [Adrenal Insufficiency].
    Burger-Stritt S, Hahner S.
    Dtsch Med Wochenschr; 2016 Nov 09; 141(24):1740-1742. PubMed ID: 27903023
    [Abstract] [Full Text] [Related]

  • 19. Management of steroid replacement in adrenal insufficiency.
    Koetz K, Kienitz T, Quinkler M.
    Minerva Endocrinol; 2010 Jun 09; 35(2):61-72. PubMed ID: 20595936
    [Abstract] [Full Text] [Related]

  • 20. Adrenal response to glucocorticoid treatment.
    Kasperlik-Saluska AA, Slowińska-Srzednicka J.
    Lancet; 2000 Apr 22; 355(9213):1459. PubMed ID: 10791544
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.